Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease

NCT01233960 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
73
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Mesoblast, Inc.